Full Breakdown
Debi Weiss's Journey Through Lymphoma and CAR-T Immunotherapy
3/7/2026, 9:54:13 PM
Diagnosis and Initial Treatment
In January 2024, Debi Weiss, a Pilates instructor, began experiencing severe fatigue and shortness of breath, initially attributing her symptoms to the flu. However, by March 2024, after consulting her primary care provider, she was diagnosed with diffuse large B-cell lymphoma, an aggressive form of cancer. Weiss described the diagnosis as a "shock," given her prior familiarity with the disease through her work with the Leukemia and Lymphoma Society. Following chemotherapy, which initially seemed effective, Weiss faced a recurrence of the lymphoma in her brain, leading to a grim prognosis. Dr. Charles Farber, her hematologist-oncologist at Atlantic Health Morristown Medical Center, indicated that traditional chemotherapy was not a viable option for her recurrent cancer.
CAR-T Immunotherapy: A New Hope
In January 2025, Weiss began a personalized immunotherapy treatment known as CAR-T therapy. This innovative approach involves extracting a patient's T-cells, genetically modifying them to target cancer cells, and reinfusing them into the body. Dr. Mohamad Cherry, the medical director of hematology at Atlantic Health, noted that the infusion process is relatively quick, taking only 20 to 30 minutes. While CAR-T therapy can have side effects, Weiss experienced none and responded positively to the treatment. She humorously likened the process to a video game, envisioning her engineered cells as "Pac-Man" devouring cancer cells. After her hospital stay, Weiss transitioned back to her daily life, including walking her dog and returning to work.
Recovery and Remission
Following her CAR-T treatment, Weiss was closely monitored by her medical team. Dr. Cherry confirmed that she is now "in complete remission" with no evidence of disease. Weiss will continue to undergo regular scans every four to six months to ensure the lymphoma does not return. Dr. Farber indicated that if the cancer remains absent for three years, it is unlikely to recur.
Life After Cancer
Weiss's experience with cancer has profoundly impacted her outlook on life. She has returned to her routine, working two part-time jobs and participating in an art therapy group with other cancer survivors. Weiss expressed a renewed perspective on priorities, emphasizing the importance of family and personal connections over work commitments. "Life is better than it was before in a lot of ways," she stated, highlighting her commitment to spending time with loved ones and being honest about her needs.
Conclusion
Debi Weiss's journey through lymphoma and her successful CAR-T immunotherapy treatment exemplifies the potential of innovative cancer therapies. Her story not only underscores the advancements in cancer treatment but also reflects the personal transformations that can arise from facing life-threatening challenges.
